864 Pill: white, capsule/oblong, 21mm
The pill with imprint 864 (White, Capsule/Oblong, 21mm) has been identified as Topiramate Extended-Release 50 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for 864
Topiramate Extended-Release
- Imprint
- 864
- Strength
- 50 mg
- Color
- White
- Size
- 21.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0864
- Inactive Ingredients
-
ethylcellulose,
isopropyl alcohol,
hypromelloses,
hydrogenated castor oil,
microcrystalline cellulose,
povidone,
polyethylene glycol,
magnesium silicate,
triethyl citrate,
gelatin,
sodium lauryl sulfate,
titanium dioxide,
butyl alcohol,
alcohol,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac,
ammonia,
water
Note: Inactive ingredients may vary.
Related images for "864"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,339)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.